Cochrane review of COVID-19 vaccines shows they are effective
A comprehensive review of all the evidence available from randomised controlled trials of COVID 19 vaccines up to November 2021 has concluded that most protect against infection and severe or critical illness caused by the virus.The review, a collaboration of independent, international experts, also found there was little or no difference between the number of people experiencing serious side effects after vaccination compared to those who were unvaccinated.The researchers, led by Isabelle Boutron, Professor of Epidemiology at Université Paris Cit é and Director of Cochrane France, analysed published data from 41 randomi...
Source: Cochrane News and Events - November 18, 2022 Category: Information Technology Authors: Muriah Umoquit Source Type: news
Venous Thromboembolism After Total Shoulder Arthroplasty Venous Thromboembolism After Total Shoulder Arthroplasty
How often do total shoulder arthroplasty patients develop venous thromboembolism, and what are the risk factors?Journal of the American Academy of Orthopaedic Surgeons (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 18, 2022 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news
Coronary thrombosis after European adder bite in a patient on dual antiplatelet therapy: a case report - Bernasconi L, Schicchi A, Pirozzolo R, Negrini V, Scaravaggi G, Lonati D, Petrolini VM, Locatelli CA.
INTRODUCTION: Until now very few cases of an adverse cardiovascular event have been described following European viper envenomation (Aravanis et al., 1982) (Aravanis et al., 1982) (Aravanis et al., 1982) (Aravanis et al., 1982). In fact, cardiac toxicity f... (Source: SafetyLit)
Source: SafetyLit - November 12, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
EHR-based Thromboembolism Risk Tools Boosts Prophylaxis EHR-based Thromboembolism Risk Tools Boosts Prophylaxis
A clinical decision-support tool designed to identify hospitalized patients in need of VTE prophylaxis cut the rate of thromboembolism at 30 days in the randomized IMPROVE-DD VTE trial.MDedge News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 8, 2022 Category: Consumer Health News Tags: Cardiology News Source Type: news
Challenges of Artificial Intelligence Models in Thrombosis Challenges of Artificial Intelligence Models in Thrombosis
Data quality, quantity, and privacy are challenges for learning models in thrombosis. These emerging tools require more trained staff and patient input to become established in clinical practice.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 8, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Combo Thrombolytic Approach Fails to Reduce ICH in Stroke Combo Thrombolytic Approach Fails to Reduce ICH in Stroke
The DUMAS study showed no benefit on the primary outcome of all ICH with low-dose alteplase followed by mutant pro-urokinase; but there were promising signs of a potential reduced bleeding risk.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 2, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Study links AstraZeneca's Covid vaccine to higher risk of very rare clot
Several countries have already altered their advice after previous research indicated that, in rare number of cases, thrombosis with thrombocytopenia syndrome (TTS) can be a possible side effect of Covid vaccines that use an adenovirus vector, or "engineered" virus, such as those from AstraZeneca and Johnson& Johnson. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 27, 2022 Category: Pharmaceuticals Source Type: news
JAK Inhibitors Show No Excess CV Safety Signal JAK Inhibitors Show No Excess CV Safety Signal
Compared with adalimumab, JAK inhibitors presented no higher risk for major adverse cardiovascular events or venous thromboembolism in patients with rheumatoid arthritis.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 20, 2022 Category: Cardiology Tags: Rheumatology News Source Type: news
Interventions Can Improve Administration of VTE Prophylaxis
MONDAY, Oct. 3, 2022 -- An electronic alert-triggered, patient-centered education bundle intervention or a nurse feedback intervention can improve administration of venous thromboembolism (VTE) prophylaxis, according to a study published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 3, 2022 Category: Pharmaceuticals Source Type: news
PROACT Xa Trial of Apixaban With On-X Heart Valve Stopped PROACT Xa Trial of Apixaban With On-X Heart Valve Stopped
The DSMB cited a lack of evidence supporting noninferiority of apixaban over warfarin for valve thrombosis and thromboembolism.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 29, 2022 Category: Intensive Care Tags: Cardiology News Source Type: news
Blood clots: Drinking wine could make blood 'less sticky' - how much you should have
Research suggests that resveratrol in red wine may be associated with an anti-thrombotic profile, and high consumption of these nutrients may lower the risk of venous thromboembolism. (Source: Daily Express - Health)
Source: Daily Express - Health - September 28, 2022 Category: Consumer Health News Source Type: news
Cerebral Venous Sinus Thrombosis in Patients With COVID-19 Cerebral Venous Sinus Thrombosis in Patients With COVID-19
While cerebral venous sinus thrombosis is rare in the non-COVID general population, this study found a high incidence in patients hospitalized with COVID-19.Stroke (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 27, 2022 Category: Intensive Care Tags: Neurology & Neurosurgery Journal Article Source Type: news
The TAVR Subclinical Leaflet Thrombosis Puzzle The TAVR Subclinical Leaflet Thrombosis Puzzle
Two recent studies address some important missing aspects of the puzzle of subclinical leaflet thrombosis, which is present in up to 10% to 15% of patients after TAVR---but questions still remain.Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 26, 2022 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Blood clot warning: Five foods that could ‘keep blood from moving’ - ‘steer clear’
Foods that contribute to a build-up of plaque in the arteries may also predispose the body to other diseases through inflammation, researchers warn. These, in time, could start interfering with the body's blood clotting mechanisms and pave the way to deep vein thrombosis. (Source: Daily Express - Health)
Source: Daily Express - Health - September 17, 2022 Category: Consumer Health News Source Type: news
Prevalence of cerebral sinovenous thrombosis in abusive head trauma - Burtard C, Panks J, Silverman LB, Lindberg DM, Stence NV, Neuberger I, Maloney J, White C, Mirsky DM.
The objective of this study was to determine the prevalence of CSVT and subdural hemorrhage (SD... (Source: SafetyLit)
Source: SafetyLit - September 13, 2022 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
